ENDOGENOUS CUSHING'S SYNDROME

Clinical trials for ENDOGENOUS CUSHING'S SYNDROME explained in plain language.

Never miss a new study

Get alerted when new ENDOGENOUS CUSHING'S SYNDROME trials appear

Sign up with your email to follow new studies for ENDOGENOUS CUSHING'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Tracking a Cushing's syndrome drug in Real-World patients for 3 years

Disease control Ongoing

This study is observing patients with Cushing's syndrome who are already taking the medication osilodrostat in their regular care. Researchers will follow about 200 patients for up to 3 years to collect information on the drug's long-term safety and how well it works to control t…

Matched conditions: ENDOGENOUS CUSHING'S SYNDROME

Sponsor: RECORDATI GROUP • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

ENDOGENOUS CUSHING'S SYNDROME

Get alerted when new ENDOGENOUS CUSHING'S SYNDROME trials appear

Tracking a Cushing's syndrome drug in Real-World patients for 3 years